Salbutamol or mist in <font color="blue">acute_2</font> <font color="blue">bronchiolitis_2</font> <font color="blue">._2</font> 
<br>
<br> BACKGROUND The role of bronchodilators in the treatment of <font color="blue">bronchiolitis_1</font> remains controversial . 
<br> METHODS A double - blind , placebo controlled trial was performed to evaluate the clinical response to nebulized salbutamol . <font color="blue">One_7</font> <font color="blue">hundred_7</font> <font color="blue">and_7</font> <font color="blue">fifty_7</font> <font color="blue">-_7</font> <font color="blue">six_7</font> <font color="blue">infants_7</font> <font color="blue">aged_6</font> <font color="blue">between_6</font> <font color="blue">7_6</font> <font color="blue">weeks_6</font> <font color="blue">and_6</font> <font color="blue">24_6</font> <font color="blue">months_6</font> <font color="blue">who_5</font> <font color="blue">had_5</font> <font color="blue">had_5</font> <font color="blue">an_5</font> <font color="blue">episode_5</font> <font color="blue">of_5</font> <font color="blue">wheezing_5</font> <font color="blue">and_5</font> <font color="blue">other_5</font> <font color="blue">signs_5</font> <font color="blue">and_5</font> <font color="blue">symptoms_5</font> <font color="blue">of_5</font> <font color="blue">bronchiolitis_5</font> were randomized to <font color="blue">three_1</font> <font color="blue">groups_1</font> as follows : ( i ) nebulized salbutamol was administered to <font color="blue">52_2</font> <font color="blue">patients_2</font> <font color="blue">in_2</font> <font color="blue">group_2</font> <font color="blue">I_2</font> at a dose of 0.15 mg / kg in 2 mL saline ; ( ii ) saline was nebulized to <font color="blue">52_2</font> <font color="blue">patients_2</font> <font color="blue">in_2</font> <font color="blue">group_2</font> <font color="blue">II_2</font> and ( iii ) in <font color="blue">group_2</font> <font color="blue">III_2</font> <font color="blue">52_2</font> <font color="blue">patients_2</font> received mist in a tent . All <font color="blue">three_2</font> <font color="blue">groups_2</font> were administered oxygen during the procedures . Treatment was repeated with the same agent after 30 min if the respiratory score was 5 or more . Respiratory rate , heart rate , oxygen saturation and presence of cyanosis , wheezing , retractions were recorded before and after each treatment . 
<br> RESULTS The decrease in the respiratory score was 5.2 + /- 1.8 , 0.82 + /- 2.4 and 1.7 + /- 1.3 in <font color="blue">group_1</font> <font color="blue">I_1</font> <font color="blue">,_1</font> <font color="blue">II_1</font> <font color="blue">and_1</font> <font color="blue">III_1</font> <font color="blue">,_1</font> respectively . The decrease in <font color="blue">group_2</font> <font color="blue">I_2</font> was significantly higher than in the <font color="blue">other_1</font> <font color="blue">groups_2</font> <font color="blue">._2</font> Heart rate was similar between <font color="blue">groups_2</font> <font color="blue">._2</font> Oxygen saturation decreased in <font color="blue">group_2</font> <font color="blue">I_2</font> without reaching statistical significance . 
<br> CONCLUSIONS Salbutamol was shown to be effective and safe in the treatment of <font color="blue">acute_1</font> <font color="blue">bronchiolitis_1</font> <font color="blue">._1</font>